Aetna Gives Priority to Hepatitis C Drugs Sovaldi and Harvoni

[mwright]

Aetna, the third-largest U.S. health insurer, has negotiated a deal with Gilead Sciences to prioritize its new hepatitis C virus (HCV) treatments, Reuters reports. Read more: bit.ly/1KomvTK